Emalex Biosciences is a biopharmaceutical company dedicated to the development of new and novel treatments. Founded in 2018, Emalex Biosciences is backed by investors that include Fidelity Management and Research Company, Valor Equity Partners, Paragon Biosciences, and LLC and is headquartered in Northbrook.
INDUSTRY:
Biotechnology, Pharmaceutical
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
